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Opa1“The large scale remodeling of mitochondria during apoptosis is a necessary step for the complete release of
cytochrome c” has been a tenet since 2002. However, more recent ﬁndings strongly indicate that the large-
scale remodeling previously described actually takes place after the release of cytochrome c and in a caspase-
dependent manner, bringing into question whether mitochondria remodeling is necessary. In a more recent
article, however, it was shown that a much more subtle form of remodeling is taking place which is only
observable by electron tomography. In the Bcl-2 inhibitable Bax/Bak-dependent intrinsic pathway of
apoptosis, the release of cytochrome c from mitochondria is a consequence of two carefully coordinated
events: formation of outer membrane pores and opening of crista junctions triggered by Opa1 oligomer
disassembly, and both steps are necessary for the complete release of cytochrome c. We review the recent
literature pertaining to the coordinated release of cytochrome c during cell death.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionOnce cytochrome c is released from mitochondria and activates
apoptosomes in the cytosol, death is the certain outcome for the host
cell. What happens to the cell's mitochondria, on the other hand, is
turning out to be a very complicated story. Adding to the complexity is
that this organelle has three distinct compartments deﬁned by two
distinct membranes [1] (Fig. 1) that separate functionality. Co-
incubation of isolated mitochondria with recombinant BH3-only
proteins or peptides triggers the rapid and complete release of
cytochrome c [2–4]. Other proteins such as Htra2/Omi, SMAC and
Opa1 are released at about the same time. Currently, the mitochon-
drial community has a very limited understanding of how BH3-only
proteins initiate this process.
It has been speculated that in order to release cytochrome c and
other proteins, pores must be formed on the outer membrane of
mitochondria [5, 6]. This pore is called the mitochondrial outer
membrane pore (MOMP), its formation is triggered by tBid [7], and
supposedly contains Bak or Bax proteins but VDAC channels are not
involved [8]. It has also been speculated that cristae remodeling is a
necessary part of cytochrome c release. There are a number of
excellent reviews regarding the ﬁrst speculation [9–11]. In this review,
we will focus on the second speculation and address the question, “Is
cristae remodeling necessary for the rapid and complete release of
cytochrome c?”.
ll rights reserved.2. The nature of cristae remodeling
Dramatic morphological changes of mitochondria are observed in
cells undertaking apoptosis. Upon apoptotic stimulation in many
situations, mitochondria change from a ﬁlamentous network into
punctate fragments. Electron microscopic images revealed that the
cristae, which are normally tubular or lamellar structures, become
roundish and fragmented and then they disappear [12]. Blebbing of
the matrix and extensive swelling of the mitochondria can occur,
followed by the fragmentation of the mitochondria [2,5]. The release
of cytochrome c from mitochondria activates apoptosome formation
in the cytosol, and is a necessary step in mitochondrial-dependent
apoptosis [13–16]. However, the question of whether large-scale
morphological changes of mitochondria are necessary for the release
of cytochrome c or the consequence of the released cytochrome c
activating apoptosomes and altering mitochondria downstream has
been a controversial issue. Proponents of the former model suggest
that crista junctions, which are narrow tubular tunnels connecting
cristae to the space between the outer and inner membranes, called
the intermembrane space, must becomewider to allow the passage of
cytochrome c from the intracristal space to this intermembrane space.
Once in the intermembrane space, cytochrome c can escape to the
cytosol through the pores formed on the outer membrane. In this
article, we present recent evidence with commonly used mechanisms
to induce apoptosis favoring the latter model, being that more subtle
forms of structural changes are taking place inside mitochondria.
Among these changes are (1) narrowing of crista junction openings,
and (2) disassembly of Opa1 protein complexes at the opening. We
also discuss what this model suggests towards our understanding of
mitochondria.
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Doug Green and colleagues observed that when HeLa cells stably
expressing GFP-Cyt Cwere stimulated with STS, Act D or UV to induce
apoptosis, within each single cell the entire content of GFP-Cyt C was
released from all themitochondriawithin 10min [17,18]. Furthermore,
they found that transmembrane potentials of mitochondria were
retained for at least 60min from the time of cytochrome c release [19].
Several years later, Terry Frey et al. used correlated light microscopy
and electron tomography to examine the 3D structures of mitochon-
dria in cells that released GFP-Cyt C and found that in the presence of
the pan-caspase inhibitor z-VAD, HeLa cells released the content of
GFP-Cyt C frommitochondria with the same kinetics as in the absence
of z-VAD [20]. Interestingly, little large-scale alterations of mitochon-
dria took place in the presence of z-VAD. These recent observations
suggest that large-scale morphological changes in mitochondria upon
initiation of several forms of apoptosis are not necessary for the
release of cytochrome c, but rather are the consequences of released
cytochrome c activating cytosolic caspases. However, the warning was
raised that immuno-ﬂuorescent microscopy cannot distinguish
different compartments of mitochondria. Thus, it was possible that
GFP-Cyt C may be localized differently from endogenous cytochrome
c, i.e., GFP-Cyt C could be residing only in locations adjacent to the
outer membranes and thus remodeling of cristae was not required for
release of GFP-Cyt C. The release of endogenous cytochrome c that
resides in portions of cristae deep within mitochondria may still
require cristae remodeling or other structural alterations. To address
this question, researchers turned to in vitro experiments using isolated
mitochondria incubated with the BH3-only proteins tBid, BimS and
with BH3 peptides [4].
In in vitro experiments, isolated mouse liver mitochondria released
the entire content of cytochrome c in 10–15min in the presence of 10–
20 nM tBid or BimS. However, the gross morphologies of treated and
untreated mitochondria were virtually indistinguishable by transmis-
sion electron microscopy. Upon further analysis of mitochondria that
released the entire content of cytochrome c using 3D tomography, it
was found that the diameter of crista junctions was actually smaller.
The release of cytochrome c was inhibited by the addition of excessFig. 1.Model of mitochondria based on EM tomography. Mitochondria have three distinct co
parts, the cristae membranes and the inner boundary membrane. Recent application of electr
by narrow, tubular structures termed crista junctions. These junctions have been propos
mitochondrial compartments. An example is the redistribution of cytochrome c and other m
mitochondrion generated from an electron tomographic volume. Scale=100 nm. (B) A moanti-apoptotic proteins such as Bcl-XL and Mcl1 [4]. It has been
estimated that over 85% of cytochrome c resides in cristae as opposed
to the intermembrane space. The release of nearly 100% of cytochrome
c must mean the release of most if not all the cytochrome c from
within cristae within 10–15 min through narrowed crista junctions.
Thus, essentially all cytochrome c can exit cristae and cross the outer
membrane in as short as 10 min without large-scale structural
alterations.
4. Molecular requirement for cytochrome c release at the
mitochondrial outer membrane
How does cytochrome c traverse the mitochondrial outer mem-
brane? The current model is that BH3-only pro-apoptotic proteins
induce the formation of Bak and Bax oligomers, which then triggers
pore formation through which cytochrome c and other intermem-
brane space proteins escape during apoptosis. Supporting this model
is the observation that in the absence of Bak or Bax oligomerization,
there is no cytochrome c release [21]. Examples are (1) in Bax/Bak
double knockout cells tBid does not induce cytochrome c release from
mitochondria [22], (2) addition of a recombinant mutant of tBid, G94E
(tBid carrying a mutation in the BH3 domain) to mitochondria from
wild-type mice does not induce Bak oligomerization, and does not
induce apoptosis, (3) addition of excess anti-apoptotic proteins such
as Bcl-XL or Mcl1 blocks tBid and BimS-induced Bak oligomerization
and blocks apoptosis, and (4) chemical agents such as DCIC, MG132
and Ucf101 block Bak oligomerization and block apoptosis [4].
Experiments with mitochondrial outer membrane vesicles (OMV)
loaded with GFP-dextran of various sizes up to several hundred kDa,
also indicated the requirement of Bax or Bak for the tBid-induced
dextran release from OMV [23].
It is not yet known what other proteins if any are involved in
MOMP formation during apoptosis through which cytochrome c is
released. It is understood, however, that the VDAC ion channel is not
necessary for tBid-induced cytochrome c release [8]. The complication
in determining the composition of the outer membrane pores rests
with the fact that it is difﬁcult to capture the images of cytochrome c
being released through the pores [7].mpartments separated by two membrane systems. The inner membrane consists of two
on tomography produced the current view that these membrane domains are connected
ed to regulate the dynamic distribution of proteins, lipids, and metabolites between
itochondrial proteins during apoptosis. (A) A surface-rendered view of an isolated liver
del of the crista junction in relation to mitochondrial compartments.
1 Our buffer composition was 300 mM Trehalose, 80–100 m MKCl, 20 mM Hepes pH
7.4, 1 mM EDTA, 1 mM EGTA, 0.1% BSA supplemented with ATP regenerating system
(5 mM succinate, 2 mM ATP, 10 mM phosphocreatine, and 10 mg/ml creatine kinase).
Scorrano's group used 125–150 mM KCl, 10 mM Tris–MOPS pH 7.4, 1 mM Pi, 5 mM
glutamate, 2.5 mM malate, and 10 μM EGTA.
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complete release of cytochrome c
The evidence we discussed so far points towards a simple model in
which pro-apoptotic BH3-only proteins induce outer membrane pore
formation through which the entire content of cytochrome c is
released into the cytosol and large-scale alterations of mitochondrial
morphologies are the consequences of cytochrome c activating
apoptosomes in the cytosol. As we discuss in this section, however,
subtle but signiﬁcant discrepancies in this model were found. For
example, it was found that the addition of MG132 blocked tBid-
induced cytochrome c release by blocking Bak oligomerization [4].
When these mitochondria were analyzed by EM tomography, the
average radius of crista junctions was 8.5 nm, about half the radius of
crista junctions in untreated mitochondria (average 16 nm). In fact,
the average radius was almost the same for crista junctions of
mitochondria treated with tBid alone. Thus in the presence of MG132
and tBid, crista junctions narrowed while there were no pores on the
outer membrane. When the accessibility of cytochrome c from the
outer membrane was measured, it was found to be as accessible as
cytochrome c in tBid-treated mitochondria. A search for a molecular
marker for these subtly remodeled cristae found Opa1.
In isolated mitochondria, about 50% of Opa1 proteins are found in
an oligomeric complex [4,24]. During tBid-treatment, oligomerized
Opa1 complexes disappear rapidly, leaving only the monomeric form
of Opa1 [4,24,25]. When isolated mitochondria were treated with
MG132 and tBid, cytochrome c and Htra2/Omi as well as Opa1 were
all retained, but there was no Opa1 complex. This led us to speculate
that Opa1 complex assembly and disassembly regulate cytochrome c
release from inside the cristae. One could imagine the Opa1 complex
acting as a gate at crista junctions, retaining cytochrome c in the
cristae under normal circumstances. During apoptosis, the Opa1
complex is disassembled by processes independent of caspases. When
the gates collapse, they leave holes large enough to let through
cytochrome c and many other proteins. But when there is no pore at
the outer membrane, cytochrome c is still trapped inside the
mitochondria. This model was tested by engineering a situation in
which the outer membrane pores were formed but the Opa1 gates
remained intact. To accomplish this, a point mutation in Opa1 was
found which made the Opa1 protein resistant to disassembly. When
this mutant protein was over-expressed in tissue culture cells and
treated with apoptosis-inducing drugs, mitochondria released very
little cytochrome c and became resistant to apoptosis. It was
concluded that Opa1 controls passage of cytochrome c through crista
junctions.
Thus how Opa1 oligomers are assembled and disassembled is a
question central to understanding the molecular mechanism of tBid-
induced cytochrome c release, and will be discussed later. But before
we go on, we will address the differences between conﬂicting
ﬁndings.
6. Two versions of the same incident — the Rashomon effect
Controversy is nothing new to Science. It often happens that
competing camps with different models ﬁght for a while only to
ﬁnd years later that no model was completely right. Further
experimentation and/or analysis seems to always resolve these
controversies. To resolve the different conclusions between Scorra-
no's group and our group, additional analysis is worthwhile because
both groups used almost the same reagents [2,4,24]. Thus, we shall
look more closely to the published articles and compared methods
used and data derived from the experiments by Scorrano's group
and ours.
Scorrano et al. used isolated mouse liver mitochondria as did we.
However, they incubated the mitochondria with recombinant tBid
protein in a buffer containing very little metal chelator (10 μM EGTA)compared to our buffer (1 mM EGTA and 1 mM EDTA) [2,4].1 We both
saw a rapid release of cytochrome c. Using a different buffer, however,
they saw changes in mitochondrial morphology, such as extensive
vesiculation of cristae followed by swelling of mitochondria, whereas
we saw only a subtle structural change — the narrowing of crista
junction diameter from 16 nm to 8.7 nm, which was only observable
with EM tomography. Scorrano et al. classiﬁed the features of altered
mitochondria into 4 classes [2]; Class I being untreated mitochondria,
Class II showing extensively vesiculated crista structures, Class III
mitochondria having asymmetric blebbing of the matrix, often with
partially ruptured outer membranes. Swollen mitochondria with
ruptured outer membranes, completely devoid of cristae structures
are classiﬁed as Class IV. Within 2–5 min of incubation with tBid,
Classes II–IV become more predominant. Using EM tomography, they
too measured the diameter of crista junctions. In untreated mitochon-
dria, the diameter of crista junctions was approximately 18.6 nm,
similar to ours. However, in later phases, the average diameter
increased to as much as 56.6 nm.
The morphologies of isolated mitochondria treated with tBid in
low EGTA buffer are signiﬁcantly different from the mitochondrial
remodeling in HeLa cells undergoing etoposide-induced apoptosis
described by Frey et al. [20], who categorized the progression of
mitochondria during apoptosis in three stages. In the correlated light
and EM studies by Sun et al. [20], mitochondria in stages 2 and 3 had
already released the entire content of cytochrome c. Furthermore, in
the presence of the pan-caspase inhibitor z-VAD, mitochondria in
HeLa cells released the entire content of cytochrome c without ever
reaching stages 2 and 3. Indeed, they found that the average diameter
of crista junctions in etoposide+z-VAD treated HeLa cells was not
different than before the treatment. Thus, it appears that extensive
remodeling of cristae structures including the widening of the crista
junctions is unnecessary for the complete release of cytochrome c.
In a more recent article, Scorrano et al. found that over-expression
of Opa1 delays the onset of cytochrome c release triggered by various
apoptosis-inducers in tissue culture cells [24]. Indeed, when mito-
chondria isolated from Opa1 over-expressing cells were treated with
tBid, there were considerably fewer mitochondria in Classes II–IV, and
the average diameter of crista junctions remained almost unchanged
(16.1±2.1 nm for untreated cells, 15.2±2.3 nm for Opa1 over-
expressing cells and 17.1±2.1 nm for cells over-expressing K301A
mutant). When isolated mitochondria from wild-type cells and Opa1
over-expressing cells were treated with tBid, the crista junction
diameter widened only in mitochondria from wild-type cells (45.4±
3.2 nm for wt mouse embryonic ﬁbroblasts (MEFs) and 20.2±3.1 nm
for Opa1 over-expressing MEFs). They interpreted this result as
evidence that Opa1 over-expression blocked thewidening of the crista
junctions, preventing cytochrome c release. Another possible inter-
pretation would be that in the presence of an increased amount of
Opa1 protein, fewer mitochondria had released cytochrome c and
transitioned to Classes II–IV mitochondria. Thus, the majority of
mitochondria might have remained in Class I with relatively narrow
crista junctions. It is worth mentioning that over-expression of Opa1
by itself does not change the average diameter of crista junctions,
suggesting that cytochrome c is not sequestered in the cristae by
making crista junctions narrower. The conclusion is that widening of
crista junctions is not necessary for the release of cytochrome c.
Even if mitochondrial cristae remodeling takes place only after
cytochrome c release, it would be of some interest to know what
causes these changes. We can only speculate at this point. The obvious
candidates to bring about morphological changes would be caspases
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blocked these changes. It would be interesting to test what effect z-
VAD would have on isolated mitochondria in low EGTA buffer when
cytochrome c is released by adding recombinant tBid. Would
remodeling of mitochondria take place? If z-VAD were to block the
remodeling then maybe a mitochondrial z-VAD binding protein could
be identiﬁed. There are actually candidate binding proteins — two
caspases. Caspase 9 has been found inside mitochondria [26] and
caspase 3 has been shown to act on complex I on the mitochondrial
inner membrane [26a]. Since the presence of 1 mM EGTA and 1 mM
EDTA block mitochondria crista remodeling, caspases could be the
metalloproteases present in mitochondria that inﬂuence the remodel-
ing. One other possibility is the release of calcium from the
endoplasmic reticulum (ER) to trigger these changes. Since the ER is
tethered to mitochondria by Mitofusion 2 [27], it is possible and also
likely that the ER is present in many isolated mitochondria prepara-
tions. Perhaps tBid could induce calcium release from the ER causing
mitochondria to swell, although a mechanism for this is unknown.
However, if this were the mechanism, then cyclosporine A (CsA)
would block the swelling, and possibly the release of cytochrome c.
Interestingly, Scorrano et al. reported that CsA attenuated the release
of cytochrome c from isolated mouse liver mitochondria, and also
blocked the remodeling of cristae structures in mitochondria [2].
Furthermore, the remodeling did not require the BH3 domain of tBid,
and was independent of the Bak protein [2]. On the other hand, we
could not block tBid-induced cytochrome c by CsA, and the same G94E
mutant of tBid used by Scorrano et al. could not induce the release of
cytochrome c, whereas other BH3 only proteins such as BimS and BH3
peptides could [4]. It is perhaps worth noting that Frey et al. also found
that pre-treatment of HeLa cells with CsA could not block the swelling
of mitochondria induced by etoposide [20].
Disagreement about the effectiveness of CsA as an inhibitor of
apoptosis is not just between three groups but is more widespread
among the community. For example, using mouse liver mitochondria,
it was suggested that CsA did not inhibit tBid-induced cytochrome c
release [28], whereas another concluded the opposite [29]. These
articles reported the use of isolated mouse liver mitochondria2 with
recombinant tBid and 1–3 μM of CsA. However, the buffers used for
mitochondrial suspension were slightly different. Why such discre-
pancies among the scientiﬁc community is open for debate.
The anti-apoptotic effect of CsA on H2O2-treated cells is even more
controversial. Some have claimed it to be inhibitory, whereas others
have shown it to be ineffective [31,32]. The reason for the discrepancy
may lie in the fact that H2O2 can initiate at least two different cell
death pathways and which pathway is activated may depend on the
cell type. The subject will be discussed later in this review. On the
effectiveness of CsA related to cell death, however, there is at least one
consensus and that is that CsA is effective in blocking nitrogen oxide-
induced neural cells death [30].
7. The last step in the release of cytochrome c: how to break the
cardiolipin–cytochrome c association?
BH3-only proteins induce outer membrane pore formation and
open crista junctions by disassembling Opa1 oligomers, but many
researchers now think that these events are not enough for the rapid
and complete release of cytochrome c. In low salt buffer, they are
enough to release intermembrane space proteins, such as short
membrane-free Opa1 and Htar2/Omi [4], but not cytochrome c.
Cardiolipin is a charged lipid almost exclusively found in the
mitochondrial inner membrane where it constitutes about 20% of
the total lipids [31]. There is an electrostatic force between
cytochrome c and cardiolipin and unless this weak interaction is2 This is important since some laboratories use rat liver mitochondria which contain
very little Bak or Bax, producing very different results.broken, it keeps cytochrome c inside mitochondria [32–34]. Indeed,
when isolated mitochondria are incubated with recombinant tBid in
buffer containing 10 mM KCl along with 300 M trehalose with or
without metal chelators such as EGTA or EDTA, Opa1 oligomers are
disassembled, opening crista junctions and releasing short-formOpa1,
Htra2/Omi, and AK very rapidly [4,35]. However almost all cyto-
chrome c remains within mitochondria. When the KCl concentration
is raised to 60–80 mM, the complete release of cytochrome c is seen
[4,36]. Intracellular concentration of K+ is estimated to be around
150 mM, more than enough to release cytochrome c from tBid-treated
mitochondria. However, this concentration may include stored K+ in
places such as mitochondria.
Supposing that we need to disrupt cardiolipin–cytochrome c
interaction, one possibility is that calcium or other ions have entered
the mitochondrial intracristal space, changing the ionic strength, and
thus releasing cytochrome c from cardiolipin. K+ and Ca2+ are stored
in the mitochondrial matrix [37]. However, since isolated mitochon-
dria incubated with tBid do not release cytochrome c unless a large
amount of KCl is added to the buffer, it seems reasonable to assume
that the source of ion must come from outside the organelle. Another
possibility is that cardiolipin is modiﬁed by reactive oxygen species
(ROS) generated by altered respiratory chain reactions (both are
reviewed in [38]). Here, we will brieﬂy review the current knowledge
regarding these two hypotheses.
Hypothesis 1. Calcium inﬂux disrupts cardiolipin–cytochrome c
association during tBid-induced apoptosis.
Apoptotic agents such as STS and etoposide that generate cleaved
tBid also trigger inﬂux of Ca2+ from the endoplasmic reticulum (ER).
Could release of Ca2+ displace cardiolipin from cytochrome c and is it
necessary for tBid-induced cytochrome c release?
When a large pool of Ca2+ is released from the ER, a signiﬁcant
fraction is quickly absorbed by mitochondria in very close contacts
with the ER [39,40] and Ca2+ ends up in thematrix. In many cell types,
transfer of Ca2+ from the ER to mitochondria seems to be a carefully
coordinated event facilitated by the proximity of IP3-sensitive
channels in the ER and calcium uniporters in mitochondria [39–41].
The Bcl-2 family of proteins in part regulates IP3-sensitive
channels on the ER. For example, in PC-3, a prostate cancer cell line,
STS-treatment can completely deplete Ca2+ from the ER and there is a
concomitant increase in the Ca2+ store of mitochondria [42,43], and
over-expression of ER-targeted Bcl-2 can block this. Another example
is that Bax deﬁcient cells are almost devoid of the stored pools of Ca2+
in either the ER or in mitochondria. Thus, the Bcl-2 family of proteins
regulates Ca2+ stores onmitochondria and ER as well as the formation
of the mitochondrial outer membrane pore.
There is one well-studied consequence of calcium inﬂux: activa-
tion of mitochondria permeability transition pore (m-PTP), which is
separate from tBid-induced cytochrome c release. When the mito-
chondrial calcium level reaches a high value, it can trigger the opening
of the m-PTP, releasing all solutes less than 1500 Da from within
mitochondria. Whether cytochrome c is also released through the m-
PTP is controversial [44,45]. However, when components of them-PTP
such as cyclophilin-D and VDAC are depleted, cells still died from tBid-
induced cytochrome c release. Thus, the m-PTP is dispensable for
tBid-induced cytochrome c release. Interestingly, cyclophilin-D knock-
out mouse embryonic ﬁbroblasts (MEFs) treated with death-inducing
agents died by necrosis.
This still leaves the possibility that calcium inﬂux could participate
in tBid-induced cytochrome c release by dissociating cytochrome c
from cardiolipin. Bax deﬁcient DU145 cells have very little store of
Ca2+ in either the ER or in mitochondria. STS-treatment induced
almost no changes in the amounts of stored Ca2+ in either organelle,
but these cells released cytochrome c and died by apoptosis [42,46].
Expression of tBid in DU145 cells also induced cytochrome c release
from mitochondria and cells died by apoptosis [46]. Thus, the huge
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not required for tBid-induced cytochrome c release.
How much Ca2+ would be needed to release cytochrome c from
cardiolipin? In isolated mitochondria, it takes 60–80 mM KCl. Thus, it
could take as much as 30–40 mM Ca2+ in the intracristal space to
dissociate cytochrome c from cardiolipin. Inﬂux of huge Ca2+ waves
observed during massive Ca2+ release from the ER in cardiac
myotubes and other cell types was estimated to be in the range of
1–200 μM [47,48]. Of course, transient increases of micro-local
concentration could be higher than 200 μM. Considering that DU145
cells have very little Ca2+ stored in the ER or mitochondria, it seems
unlikely that they could generate a large enough inﬂux of Ca2+ to
dissociate cytochrome c from cardiolipin. Thus, it appears that the
inﬂux of Ca2+ is not necessary for the tBid-induced cytochrome c
release from mitochondria. Our conclusion is that Hypothesis 1 is
likely not valid.
Even though this review is focused on the Bax/Bak-dependent
intrinsic pathway of apoptosis and the internal changes that must be
made in mitochondria before cytochrome c can be released, a small
detour is in order to discuss another pathway of cell death because of
its dependence on the presence of calcium ions stored in the ER and its
potential to affect mitochondria.
8. ER-Ca2+-dependent cell death pathway
Unlike developmentally regulated programmed cell death that
uses Bak/Bax-dependent apoptosis, external injuries to tissues such as
wound healing or ischemia/reperfusion activate the ER-Ca2+-depen-
dent cell death pathway.
To distinguish Bax/Bak-dependent intrinsic pathway of apoptosis
from ER-Ca2+-dependent cell death pathway, Scorrano et al. used
Bak/Bax double knockout cells (DKO cells) [22]. These DKO cells have
little stores of Ca2+ in either ER or mitochondria. The sarco/
endoplasmic reticulum Ca2+-ATPase (SERACA) is a Ca2+ transporter.
Over-expression of SERCA enhanced Ca2+ uptake by the ER and
restored Ca2+ levels to normal in DKO cells. This restored the
sensitivity to ceramide, arachidonic acid and H2O2, but cells remained
resistant to tBid-induced cell death [22]. Transfection of mitochon-
dria-targeted Bax to DKO cells, on the other hand, restored the
sensitivity of DKO cells to STS, etoposide and BFA-treatment, without
restoring Ca2+ stores in these cells. As expected, DKO cells transfected
with mitochondria-targeted Bax died an apoptotic death when tBid
was introduced. However, these cells remained resistant to ceramide,
arachidonic acid and H2O2 [22]. Thus, these sets of experiments
showed that there exist two independent pathways of programmed
cell death. In mouse ﬁbroblasts, ceramide, arachidonic acid, and H2O2
use an ER-Ca2+-dependent programmed cell death which does not
relay on MOMP to release cytochrome c whereas the expression of
tBid triggers an ER-Ca2+ independent, Bax/Bak-dependent apoptosis,
and STS and etoposide activate both pathways.
Lastly, agents such as H2O2 and ceramide induce Ca2+ release from
the ER, which is taken up bymitochondria, and when the Ca2+ level in
mitochondria reaches a threshold concentration, it activates the
mitochondria permeability transition pores through which cyto-
chrome c escapes, activating caspases in the cytosol.3 But this is very
different from tBid-induced cytochrome c that does not require
calcium inﬂux. In tBid-induced apoptosis, cytochrome c escapes from
mitochondria through Bak/Bax pores formed on the outer membrane.
Interestingly, over-expression of Opa1 seems to delay cytochrome c
release in both pathways [49]. It is not known how or even if cristae
are remodeled during H2O2-induced or ceramide-induced cyto-3 This is suggested by Narita et al in Proc. Natl. Acad Sci USA 95 (1998). However, this
may not always be the case in all cell types. There are data indicating that treatment of
cells with H2O2 could cause caspase-independent necrotic cell death (Nakagawa et al.,
Nature 434 (2005) 652-658).chrome c release, but by the time cytochrome c is released,
mitochondria are all likely to be swollen. Thus, remodeling of
mitochondria under ER-Ca2+-induced cell death appears to be very
different from tBid-induced cytochrome c, yet Opa1 plays a role in
both of them. For this review, however, we will remain focused on
tBid-induced cytochrome c release.
Hypothesis 2. Modiﬁcation of cardiolipin disrupts cardiolipin–
cytochrome c association during tBid-induced apoptosis.
It has been reported that cardiolipin modiﬁcation takes place
during dexamethasone-induced thymocyte apoptosis [50], and p53-
induced apoptosis [51]. It was assumed that reactive oxygen species
generated during apoptosis cause peroxidation of cardiolipin. In these
studies, however, 10-N-nonyl acridine orange (NAO) was used in FACS
analysis to assay for amounts of cellular andmitochondrial cardiolipin.
However, NAO is not as speciﬁc for cardiolipin as previously believed
because cardiolipin deﬁcient yeast cells are stained positive by NAO in
in vitro and in vivo assays [52]. What is needed is a membrane
permeable cardiolipin-speciﬁc dye to observe the loss of cardiolipin
from mitochondria as cytochrome c is being released. Another useful
tool would be the recently developed system for REDOX-sensitive GFP
(roGFP), but targeted to the mitochondrial intracristal space to
monitor how changes in REDOX state in the intracristal space would
precede the loss of cardiolipin followed by the release of cytochrome c
[53–55]. Because over-expression of Opa1 delays the release of
cytochrome c when cells were treated with H2O2, it is possible that
Opa1 has a role in protecting cardiolipin from being oxidized [24].
The only accuratemeasurement of cardiolipin currently available is
by mass spectroscopy. Indeed, in STS-induced apoptosis, three anionic
phospholipids: cardiolipin, phosphatidylserine and phosphatidylino-
sitol all underwent oxidation as measured by mass spectroscopy [56],
conﬁrming lipid peroxidation of cardiolipin during apoptosis. Further-
more in actinomycin-D (ACD)-induced apoptosis inMEFs, oxidation of
cardiolipin (6 h) preceded cytochrome c release (8 h), caspase3/7
activation (8 h), annexin V positivity (9 h) and a decrease in the
transmembrane potential (12–14 h) after treatment with ACD [57],
suggesting that peroxidation of cardiolipin is not the consequence of
cytochrome c release nor a drop in the transmembrane potential.
What could be oxidizing cardiolipin? Borisenko et al. suggest that
cytochrome c is 4. Using a phospholipase-based enzymatic assay for
the presence of cardiolipin, they discovered that during apoptosis, the
distribution of cardiolipin between monolayers of inner membrane
changed from 60:40 (matrix-facing:intermembrane space-facing) to
30:70 [57]. Then using an in vitro assay, they showed that cytochrome
c can act as a cardiolipin oxygenase. They reason that a two-fold
increase in cardiolipin content directly facing the intermembrane
space may be enough to begin peroxidation of cardiolipin by
cytochrome c. The mechanism for the cardiolipin switch from the
matrix side of the lipid bilayer to the intermembrane side is unknown.
Taken altogether, it seems reasonable that a sudden emergence of
cardiolipin molecules facing the intermembrane space triggers their
own destruction, detaching cytochrome c, and preparing for the
eventual release of cytochrome c from mitochondria. If this is true,
then the intriguing question is, “How does tBid in the cytosol affect
lipids in the matrix-facing inner membrane?”
Mass spectroscopy was also used to analyze the total lipid content
of isolated mitochondria treated with tBid [58]. It was reported that
these mitochondria lost more than 50% of their cardiolipin content.
Composition of other lipids remained largely unchanged. A 50%
reduction in cardiolipin content was also observed in mitochondria
treated with tBid-G94E as well as mitochondria treated with tBid+
Bcl-XL. Thus, the reduction in cardiolipin content did not correlate
with mitochondrial outer membrane pore formations or crista4 Nature Chemical Biology 1 (2005) 223–232.
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cardiolipin in their lipid scan as an indication of tight binding of tBid to
cardiolipin [58]. Furthermore, they propose that this binding takes
place at alpha helices α4–α9 of tBid, not through helix α3 that
contains the BH3 domain. Lastly, they suggest that this binding of tBid
through its C-terminal region to cardiolipin facilitates the transloca-
tion of tBid to mitochondria. Shortly after, Walensky et al. published
evidence that a hydrocarbon-stapled BH3 helix can induce apoptosis
very efﬁciently [59]. Thus, helices α4–α9 of tBid may be serving dual
roles: one, as a mitochondrion localization signal, and two, a
cardiolipin-binding site.
It is perhaps worth mentioning that tBid does not bind to pure
cardiolipin in vitro. It does bind to cardiolipin-containing mixed-lipid
liposomes, though [38]. Furthermore, it is believed that since
cardiolipin is a charged lipid, it could attract a variety of charged
proteins such as cytochrome c, protein kinase C, tBid and caspase-8
[23,60], and often serves as a platform to assemble large protein
complexes on liposomes and on the inner membrane of mitochondria
[23,61]. In particular, cardiolipin is enriched in mitochondrial contact
sites where the mitochondrial outer and inner membranes adhere,
and where VDAC, ANT and cyclophilin-D interact. Cardiolipin can
induce hexagonal structures on liposomes in in vitro experiments and
for this reason, it is speculated that hexagonal structures are formed at
mitochondrial contact sites, exposing cardiolipins to the cytosol and
thus to tBid [62,63]. In support, Lutter and coworkers found that tBid
was localized to contact sites [64,65].
9. The role of Opa1 in maintaining cristae morphology
Mitochondria lacking Opa1 protein are largely devoid of cristae
structures [66]. However, this ﬁnding is not unique. There are many
more genes that affect the generation of cristae structures when their
protein products are depleted [1]. One example gaining increasing
interest is mitoﬁlin [67]. The loss of speciﬁc isoforms of Opa1 can
result in aberrant cristae morphogenesis and impaired cellular
proliferation [68,69,66]. Furthermore, during siRNA treatment to
inhibit Opa1 protein synthesis, the tubular network of mitochondria
in cell lines becomes fragmented, indicating that Opa1 plays a role in
mitochondrial fusion. Indeed, the yeast homologue of Opa1, Mgm1, is
necessary for yeast mitochondrial inner membrane fusion [70].
However, we do not know exactly how Opa1 maintains cristae
structures and how that is related to mitochondrial fusion activity.
Opa1 is a nuclear encoded gene and in humans, there are 8 splice
variants of Opa1 [71,69]. In most tissue culture cells, at least two to
three splice variants seem to be expressed. Each of these splice
variants carry two to three cleavage sites by serine proteases. These
sites were identiﬁed by Ishihara et al. [72] and designatedMPP, S1 and
S2. Once the product of a splice variant is imported into mitochondria,
its mitochondrial localization signal peptide is cleaved at the MPP site,
generating a mature membrane-bound Opa1 protein. Subsequently,
second and possibly third cleavages can take place at either S1, S2 or
both, producing shorter isoforms [72].
In most human and mouse cells, six isoforms of Opa1 are
detectable by western blotting: two long membrane-bound isoforms
and four short membrane-free isoforms. It is not known if each
mitochondrion houses only long isoforms, only short isoforms or both.
It is known, however, that the cells which had lost all the long
isoforms of Opa1, such as found in patients suffering from mitochon-
drial myopathies or MEFs harboring an error-prone mitochondrial
mtDNA polymerase α, contain fragmented mitochondrial networks
and have reduced mitochondrial respiration rates [73]. Introducing
various human Opa1 variants and their mutants into MEFs from Opa1
knockoutmouse embryos, David Chan et al. demonstrated that at least
one short isoform and one long membrane-bound isoform is
necessary for the generation of fusion competent mitochondria [69].
Other approaches, such as over-expression of non-cleavable mutantsor introduction of short isoforms, came to similar conclusions
[68,71,74].
Because mitochondria need both long and short isoforms to
support their fusion activity, knowing how conversion from long to
short isoforms is regulated is of great interest. One could test if the
same proteases cleave Opa1 during tBid-induced apoptosis. By
knowing the identities of Opa1 processing enzymes, perhaps drugs
could be developed to inhibit unwanted apoptosis by blocking Opa1
cleavage or do the opposite: prime tumor cells for apoptosis by
activating Opa1 processing enzymes.
There are two conditions under which the complete conversion of
all long isoforms of Opa1 to short isoforms takes place: one, during
tBid-induced apoptosis and two, during the treatment of cells with the
mitochondrial respiration inhibitor, CCCP. This latter process was
inhibited by 1,10-phenanthroline, an inhibitor of metalloproteases,
suggesting the involvement of m-AAA in the process [75]. Even
though both processes convert Opa1 long isoforms to short isoforms,
these two events differ in the way they alter cristae structures.
When isolated mitochondria are incubated with tBid, all the long
isoforms of Opa1 are quickly converted to short isoforms and it is only
the short isoforms that are released from mitochondria when Opa1
oligomers are disassembled [3]. However, the release of the short
isoforms is not completed during the 30 min in which 100% of
cytochrome c and Htra2/Omi molecules are both released. This might
be because the membrane-free short isoforms are still attached to
some other moieties in mitochondria, such as membrane-bound Parl.
In tissue culture cells, the mitochondrial transmembrane potential is
maintained for a few hours after the loss of cytochrome c [18,19]. On
the other hand, CCCP-treatment of cells, as well as of isolated
mitochondria, causes an immediate drop in the transmembrane
potential and the long isoforms of Opa1 disappear frommitochondria
in 10–30 min [75,66,69,76]. The mitochondrial network in these
cultured cells becomes fragmented. The treatment does not cause
immediate disassembly of Opa1 oligomers nor does it cause the loss of
cristae structures. However, the long-term absence of Opa1 long
isoforms seems to destabilize Opa1 complexes that eventually leads to
the loss of cristae structures [68]. Thus, the changes to Opa1 brought
on by two different treatments differ qualitatively — tBid-treatment
causes immediate disassembly of Opa1 oligomers while CCCP-
treatment cause only destabilization of Opa1 complexes.
10. Opa1 processing enzymes
Even though mitochondrial proteomes are slightly different from
tissues to tissue, there are at most 20–30 serine proteases present in
mitochondria. Three candidate serine proteases for processing mature
membrane-bound Opa1 long isoforms are paraplegin, Yme1L and
PARL. Mgm1 is cleaved by a rhomboid protease in mitochondria, Pcp1
[77]. When the mammalian homologue of Pcp1, PARL, is knocked out
in mice, a wasting phenotype characterized by increased apoptosis
was exhibited [49]. However, Parl−/− cells displayed normal
mitochondrial morphology, did not show defects in mitochondrial
fusion/ﬁssion, and did not display primary respiratory defects.
Nevertheless, Parl−/− cells were more sensitive to apoptotic stimuli,
such as etoposide, staurosporine and hydrogen peroxide. When
exogenous Opa1 proteins were expressed in Parl−/− cells, they
became less sensitized to apoptotic stimuli. Thus, it is suggested that
increased sensitivity to apoptotic stimuli in Parl−/− cells may be due
to altered Opa1 processing in these cells independent of mitochon-
drial fusion [24].
Yme1L (human Yme1-like) is an ATP-dependent membrane-
inserted metalloprotease whose active site is in the intermembrane
space thus classiﬁed as i-AAA [78]. David Chan's group showed that
Yme1L cleaves Opa1 at S2 but not S1, They also discovered that the
loss of transmembrane potential destabilized the long isoform of Opa1
and enhances the cleavage at S1 but not S2 [69]. Thus, Yme1L cannot
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isoforms. van der Bliek's group showed that cells lacking either Parl or
Yme1L responded to CCCP-treatment by cleaving the long isoforms of
Opa1 [66]. Since Yme1L cannot cleave Opa1 at S1, their data imply that
neither Parl nor Yme1L can cleave at S1. It was also found that Parl
knockout did not affect Opa1 maturation nor did it affect induced
proteolysis. Using a similar approach, Rojo's group also ruled out Parl
and SPG7 (spastic paraplegia type 7) as serine proteases that generate
short isoforms of Opa1 [76]. Reichert's group used yeast to
reconstitute human Opa1 protein processing and found that human
Parl expressed in yeast can cleave Mgm1 but not human Opa1 [79].
Ishihara et al. also expressed humanOpa1 in yeast cells lacking various
serine proteases and identiﬁed m-AAA as a candidate protease for
Opa1 processing enzyme [72]. They also ruled out the involvement of
paraplegin. In short, an S2 protease is known, but an S1 protease still
has not been identiﬁed.
What could be the role of Parl? Mitochondria in Parl-depleted cells
aremore sensitive to apoptosis-inducing agents and their sensitivity is
reversed by over-expression of Opa1. However, over-expression of
Opa1 delays the induction of apoptosis inwild-type MEFs. Thus we do
not know if Opa1 over-expression is restoring lost activity of Parl-
processed Opa1 or simply protecting mitochondria by its abundant
presence. Because Opa1 and Parl can co-precipitate each other [49], it
is possible that the role of Parl is to stabilize Opa1 oligomers by
providing an extra anchor. Stable Opa1 must be beneﬁcial to the cell,
making it more resistant to apoptosis. Not surprisingly, when wild-
type Opa1 is over-expressed in MEFs, they become more resistant to
apoptotic stimuli [24] while in Parl-depleted cells, Opa1 seems to
make the cells less resistant [49,72].
The hypothesis that the role of Parl in cristae remodeling and
apoptosis does not require its serine protease activity could be tested
by expressing Parl point mutants defective in serine protease activity
in Parl−/− cells. If expression of such a mutant in Parl−/− cells
reverses the sensitivity, then Parl protease activity is not needed, and
the role of Parl would be limited to its ability to associate with and
stabilize Opa1 oligomers.
There is one more puzzle in this story. Prohibitins 1 and 2 are inner
membrane proteins that form a large ring structure embedded in the
innermembrane facing the intermembrane space, yet able to inﬂuence
the matrix side. On the matrix side, the ring associates with an m-AAA
protease complex [80]. It is known that knocking out one of the
prohibitin genes destabilizes the proteinproduct of the other, resulting
in cells lacking both proteins. In prohibitin depleted cells, mitochon-
dria are largely devoid of cristae much like Opa1 depleted cells, and
both of the membrane-bound long isoforms of Opa1 are missing. The
forced expression of a long isoform of Opa1 suppresses these defects.
These data suggest that prohibitins regulate the serine protease(s) that
cleaves membrane-bound long isoforms of Opa1.
11. Role of Opa1 in keeping cytochrome c inside crista
Using immuno-EM, Opa1 was found localized to the outer surface
of the innermembrane seemingly throughout the intermembrane and
intracristal spaces and not just at crista junctions [71,81]. Thus it
seems that the Opa1 complex can be anywhere on the inner
membrane.
Using yeast, Reichert et al. found that when protein synthesis and
consequently mitochondrial import activities were arrested, Tim23, a
part of the inner membrane portion of the import machinery that
spans the mitochondrial inner membrane and outer membrane, was
redistributed from predominantly inner boundary membrane locali-
zation to a more even distribution between inner boundary
membranes and cristal membranes. They interpreted the results as
follows: when mitochondrial protein import was arrested, it wea-
kened the casual association between the N-terminus of Tim23 with
the corresponding transporter complex of the outer membrane (aTom), and since the C-terminus of Tim23 is embedded in the inner
membrane, Tim23 diffused into the intracristal space. Their data
suggest that there was no physical barrier blocking the lateral
movement of inner membrane proteins across crista junctions [82].
If there is no barrier between inner boundary and cristal
membranes, would there be lateral movement of cardiolipin across
crista junctions as well? We do not know the distribution of
cardiolipin since we do not yet have the means to separate inner
boundary membranes from cristal membranes. But, since cardiolipin
associating proteins such as cytochrome c and the oxidative
phosphorylation (Oxphos) complexes are predominantly located in
the cristal membranes, cardiolipin distribution might also be skewed
towards cristal membranes. Reichert's group suggests that protein–
protein associationmay also be a determinant factor for localization of
cardiolipin [82]. Using their model, one could argue that once large
complexes, such as the Oxphos complexes, are assembled, they would
not easily be diffused and could even trap charged lipids like
cardiolipin in the cristae. Furthermore, it is possible that the presence
of Opa1 stabilizes Oxphos complexes and cytochrome c associating
with them, thus keeping cytochrome c in the intracristal space. Indeed
Frezza et al. showed that over-expression of wild-type Opa1 delayed
the onset of H2O2-induced (ER-Ca2+-dependent) apoptosis [24].
What about soluble proteins and proteins that are loosely bound to
membranes such as cytochrome c? Crista junctions in normal
mitochondria can typically vary in mean diameter from 15 to 30 nm
and vary much more in length. The mean diameter can be reduced to
around 8 nmwith tBid-treatment. Even at its narrowest, a hole of that
size is big enough to let through 60–100 kDa proteins [83,84], hence it
could let through cytochrome c molecules. At the same time,
oligomerized Opa1 complexes may exceed several hundred kDa and
theymay be large enough to hinder freemovement of soluble proteins
across crista junctions.
12. Conclusion
“Happy families are all alike; every unhappy family is unhappy in
its own way.” So begins Leo Tolstoy's novel, Anna Karenina. In many
ways, studying apoptosis is like watching unhappy families. There are
many ways leading to apoptotic cell death. Even if we restrict
ourselves to the study of intrinsic forms of apoptosis, there are at
least two distinct pathways: Bax/Bak-dependent pathway, which
begins with the generation of BH3-only proteins that induce MOMP
formation on mitochondria, and the ER-Ca2+-dependent pathway,
which is triggered by calcium inﬂux from the ER. This review focused
on the molecular mechanism of tBid-induced cytochrome c release
from mitochondria (Bax/Bak-dependent pathway) and internal
changes that must take place before the release. Even though we
brieﬂy discussed the ER-Ca2+-dependent pathway for comparison
purposes, we did not discuss how cristae are remodeled during Bax/
Bak-independent ER-Ca2+-dependent cell death and the possible role
of Opa1 in this pathway, nor did we examine the possible
mechanisms of MOMP formation [7,9]. By narrowing the scope of
this review, however, we were able to more completely cover what is
known about the Bax/Bak-dependent pathway, identify key research
issues and ongoing controversies, and to even propose experiments
to help resolve these controversies. A model summarizing the
cumulative knowledge of Opa1's role in tBid-induced apoptotic
pathway is presented in Fig. 2. Even though tBid-induced cytochrome
c takes place in the middle time frame of apoptosis, it does not
happen in the way it was previously described: dying mitochondria
ﬁrst start to swell and then explode, spilling their entire contents
throughout the cytosol. Instead, the evidence points to a complex
interplay of events, causing subtle changes to mitochondrial
structures. Three events necessary for the complete release of
cytochrome c are the formation of mitochondrial outer membrane
pores, the opening of crista junctions triggered by disassembly of
Fig. 2. Crista junctions narrow upon Opa1 oligomer disassembly. (A–D) EM tomography of isolated mitochondria. Untreated mitochondria have relatively uniform crista junction
openings (arrows and arrowheads). (A) A central slice through a tomographic volume and (C) the surface rendering of the inner boundary membrane. Upon dissolution of Opa1
oligomers in tBid-treated mitochondria, the crista junction diameter narrows to about half the size as demonstrated in (B) a central slice and (D) the rendered inner boundary
membrane. Scale=100 nm for both A and B. The arrowheads point to the crista junctions in the tomographic slices and the arrows to the crista junctions in the surface-rendered
volumes. E and F show a model of Opa1 oligomer disassembly, crista junction alteration, outer membrane permeability with the Bax+Bak pore, and subsequent cytochrome c
release. Cardiolipin is almost exclusive inmitochondrial inner membranes. In this model (F), inner membranes are oxidized by ROS generated during apoptosis. By lipid peroxidation,
cardiolipin is lost from the inner membrane, releasing cytochrome c from this membrane. Cytochrome c then exits the intracristal space through opened crista junctions and
traverses the outer membrane through Bak/Bax pores into the cytosol.
970 R. Yamaguchi, G. Perkins / Biochimica et Biophysica Acta 1787 (2009) 963–972Opa1 oligomers, and the dissolution of the cardiolipin–cytochrome c
association. By examining the published evidence, one comes to
understand the intricate timing of these events and the coordinated
association of molecules that regulate this dynamic structural and
functional correlation. Unresolved issues are (1) how Opa1 oligomers
are assembled and disassembled and (2) how the electrostatic force
between cardiolipin and cytochrome c is broken. The larger issue stillto be addressed is how mitochondria cristae structure is generated
and maintained. These are important questions because subtle
defects in mitochondria are known to be the cause of premature
aging and many age-related neurodegenerative diseases [85].
Furthermore, by better understanding this intricate organelle, we
will learn how lipid and protein complexes can build and maintain
very complex structures.
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